Human travel drove Ebola spread in DR Congo, outbreak reconstruction suggests
Mary Van Beusekom, MSToday at 3:31 p.m.
Ebola
A team led by researchers in the Democratic Republic of Congo (DRC) paired case and testing records with mobile-phone data to determine that human movement—not geography or population size—propelled the spread of the Bundibugyo Ebola virus early in the ongoing outbreak that is now the country’s largest on record and the fastest-growing Ebola outbreak in history.
As of today, the US Centers for Disease Control and Prevention reports 11,463 cases, including 5,597 deaths, in the outbreak. Ebola is currently affecting 67 health zones in eight DRC provinces. Kenya has begun a 42-day countdown after the last of the country’s seven surviving Ebola patients was released from medical care. Nigeria has ended its 21-day Ebola monitoring period, with its only infected patient released from the hospital and all 62 monitored contacts cleared.
The study, published last week in Science, also suggests that the deadly virus was circulating weeks before the epidemic was declared in mid-May. It is the most detailed epidemiologic reconstruction of the rapid outbreak expansion within Ituri province and in bordering provinces so far. No approved vaccines or treatments target Bundibugyo, although a vaccine and therapeutic trial are currently under way.
Researchers quickly mobilize
As the epidemic unfolded, more than 50 researchers analyzed data based on questions from the outbreak response teams, such as the optimal locations for resource distribution and the money needed to care for infected people at hospitals and healthcare centers.In a University of Oxford news release, co-first author Pierre Akilimali, MD, PhD, of the University of Kinshasa, said, "Within days of the alert, Congolese teams were collecting, curating and analysing individual-level case data under extraordinarily difficult conditions.”
The person with the earliest known infection in the outbreak began having symptoms on April 25. An earlier sample from a suspected case was available but had invalid results as early as April 9.
Within days of the alert, Congolese teams were collecting, curating and analysing individual-level case data under extraordinarily difficult conditions.
Pierre Akilimali, MD, PhD
“Invalid results might be due to insufficient blood taken, lack of biological material from swabs of deceased patients, and/or difficulties transporting samples to the laboratory during the early phase of the outbreak, when local laboratories were just being established,” the authors wrote.
Cases rapidly increased from May 10 to June 1, when the number of health zones and areas reporting infections skyrocketed by 12 and 49, respectively. The estimated early case doubling time was 10 days.
Test positivity was highest for samples collected from people with symptom onset before May 13 (54%) and then stabilized at about 36%, likely due to the scale-up of case investigation and testing after the outbreak declaration.
Among 555 known test outcomes with documented age, sex, and symptom onset, the median age of infected patients was 34.5 years, with women accounting for 59% of confirmed cases.
Need for permanent lab, healthcare capability
While mobility alone strongly delineated health zones that did and didn’t report infections, destination population size was not predictive of disease spread. The risk of Bundibugyo invasion fell with increasing distance from Bunia and Mongbwalu in Ituri and Rwampara in Uganda, up to 100 kilometers (km; 62 miles). But then it rose slightly from 150 to 200 km (93 to 124 miles), likely due to human mobility along established travel corridors and then local growth.Co-senior authors Moritz Kraemer, DPhil, of the University of Oxford, and Samuel Scarpino, PhD, of Northeastern University, said, “Human mobility data predicted almost perfectly where this virus would appear next. We need to position laboratory and care capability permanently in these high-risk emergence settings for improved responses in the future."The current lack of medical countermeasures and rapid spatial expansion of the outbreak mean that swift and continued action is needed to control the outbreak.
Initially funded by the Gates Foundation, the group continues to support the Bundibugyo virus response and is now funded by the Coalition for Epidemic Preparedness Innovation (CEPI) as the Institut National de Recherche Biomedicale-led B-REACT network.
“The current lack of medical countermeasures and rapid spatial expansion of the outbreak mean that swift and continued action is needed to control the outbreak,” the researchers concluded.